EXPERIMENTAL and pathological investigations have shown asbestos to be associated with mesothelioma in animals and man (Wagner & Berry, 1969; Wagner et al., 1960) . In man the development of this neoplasm can take as long as [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] years after the first exposure to asbestos (Selikoff & Lee, 1978) and a comparable long latency period (18 months to 2 years) is found in rats.
Immunogenic tumour-associated transplantation antigens (TATA) are expressed on chemically induced tumours such as 3-methyleholanthrene-induced fibrosarcomas in mice (Prehn & Main, 1957) and rats (Baldwin, 1955a) . However, asbestos is a mineral the physical properties of which are a major factor in determining its carcinogenic potential (Stanton et al., 1977) . Our experiments, therefore, were undertaken to establish the presence or absence of TATA on transplantable asbestos-induced mesotheliomas. In vivo assessment of TATA was studied using excision challenge and irradiated-graft regimes.
Syngeneic PVG/C Norwegian hooded rats, obtained from Glaxo Laboratories, Greenford, Middlesex, were housed in barrier-maintained conditions. Twentysix males and 17 females between 6 and 7 weeks of age were given intrapleural injection of 20 mg of UICC crocidolite in 0 4 ml of saline (Wagner & Berry, 1969) . The tumours were transplanted and maintained by s.c. serial passage for an average of 20 generations using a trocar implantation method as described by Baldwin (1955b) . Seven tumour lines, 5 of male and 2 of female origin, have been established. As the tumours arose, they were designated Mel, Me2, as shown in Table I . Nine tumours were transplanted, 2 of which are not included in this study (one was lost due to rapid host death; another was inappropriately designated Me8, and after histological identification was redesignated ADC1). The primary morphology of the 7 remaining tumours on histological examination showed the typical dimorphic pattern of both epithelial and spindle-cell types. One tumour was of predominantly spindle-cell type. By the 4th transplant generation (TG) all but 2 of the tumours became dominated by large undifferentiated primitive cells with a high mitotic rate. All tumours showed this morphology after 6 TGs. Routine histological examination of the lungs from these animals carrying primary tumour revealed the features of chronic murine bronchitis, the increase in lymphoid tissue being most marked when the tumour had compressed the bronchi. Untreated animals also had bronchitis. The changes arose in spite of no pathogenic organisms having been found on bacteriological examination.
Transplantation of tumours was carried out between animals that were no more than 4 generations removed from common ancestry, 6 months of age or less and of the same sex.
A spontaneous lung adenocarcinoma (ADC1) was found in a crocidolite-treated rat with no signs of a mesothelioma. This tumour was maintained as a control for the mesothelioma study. The immunization regimes were based on those described by Baldwin & Barker (1967) . Five groups of comparable rats (5-8 animals/group) were used for each transplanted tumour:
Group (a). Unsensitized "normal animals" were used as direct controls. Different rats were used for each subsequent tumour challenge.
Group (b) Baldwin (1966) . The cell viability of the suspension was measured in fluorescein-diacetate-treated cells (Parazzi et al., 1968) counted in a FuchsRosenthal Haemocytometer. The animals in all groups were "scored" 30 days after tumour challenge. Absence of tumour was read as rejection. In Table I the number of tumour "takes" over the total number of animals per group is given. The upper limit of immunity was estimated bv doubling the previous dosage until all the animals in Groups (b) and (d) had palpable tumours.
The immunocompetence of the rats, using both in vivo and in vitro assays after a strong immunogenic stimulus, was assayed. These assays were as follows:
1. Positive control tumour. Strongly immunogenic tumours were induced by s.c. injection of 10 mg of 3-methylcholanthrene in 0 5 ml of Tricaprylin. Identi- cal immunization regimes to the experimental tumours were followed.
2. Allogeneic skin transplants (Festing et al., 1970) . Skin grafts of Fischer 344 rats to PVG/c were undertaken to establish immunocompetence. Isografts between members of the colony acted as controls.
3. Plaque-forming colonies estimation (Jerne et al., 1963; Cunningham, 1965 splenic lymphocytes. The same number of control animals gave 3 3 + 1P2 plaques/105 lymphocytes. Similarly, 5 females gave group means of 64 2 + 34 8 and 23 + 1 8 for control animals. Seven of 10 allografts were rejected at 21 days. Three grafts sloughed off after 2-3 days; 9 of 10 isografts from comparable donors were successfully grafted. We were satisfied that both in vivo and in vitro immune competence had been demonstrated. Embleton et al. (1976) tested allogeneic human mesothelioma cells in an in vitro lymphocytotoxicity test and reported a negative result. This in vivo study of rat mesothelioma immunogenicity also reports negative findings.
When present, in vivo rejection of tumour as measured by the excision/ challenge assay is indicative of immunogenic cell-surface antigen expression, as demonstrated in the 3-methyleholanthrene-induced fibrosarcoma. Smith & Landy (1974) , amongst others, have pointed out that negative results may arise owing to quantitative or qualitative lack of antigen expression, antigenic loss or modulation, or incorrect time oftumourcell challenge for the peak level of host immunity. A serologically defined glycoprotein specific for human mesothelioma cells and normal mesothelial cells has been described (Singh et al., 1979) which, if present in rats, is obviously not immunogenic when tested by the methods used in our experiment. Kanazawa et al. (1979) have suggested that even low levels of asbestos-dust exposure can enhance or modulate susceptibility of young mice to murine-sarcomavirus-induced oncogenesis. Arnold et al. (1976) have indeed shown that in hamsters Papova virus will induce mesotheliomas. Tumours arising as a result of viral involvement are typified by cross-reacting cell-surface antigens capable of eliciting strong tumour rejection responses as measured by excision/challenge assay (Sjogren, 1961) . We present no evidence of such a strong response to support viral synergism in the production of mesotheliomas.
The work described in this paper supports the general concept of the inability of long-latent-period tumours to stimulate host rejection through cell-surface expression of TATA. However, equal consideration must be given to the fact that a carcinogen was used the physical properties of which are important. This agent has not yet been shown to be immunosuppressive in vivo, nor have its mutagenic properties been confirmed.
